Maxim Group Upgrades Adial Pharmaceuticals Inc (ADIL) to Buy, PT $1.50 Sep 30, 2025 07:38AM
Adial Pharmaceuticals CEO to Participate in a Fireside Chat at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th Mar 22, 2022 09:15AM
Adial Pharmaceuticals Announces Closing of $10 Million Financing Feb 16, 2022 09:26AM
Adial Pharmaceuticals (ADIL) Prices 4.19M Share and Warrant Direct Offering at $2.40/sh Feb 11, 2022 09:01AM
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering Feb 11, 2022 09:00AM


Sep 15, 2021 10:07AM Adial CEO William Stilley Invited to Participate in Maxim Group’s Virtual Panel Series Conference: “Disruptors in the Mental Health Space”
Jun 15, 2020 09:30AM Adial Pharmaceuticals Closes Previously Announced $5.2 Million Registered Direct Offering
Jun 9, 2020 09:15AM Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market
Feb 26, 2019 08:00AM Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters’ Over-Allotment Option
Feb 21, 2019 08:47AM Adial Pharmaceuticals (ADIL) Prices 2.475M Common Share Offering at $3.25/Sh
Feb 21, 2019 08:45AM Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
Dec 13, 2018 12:27PM Adial Pharmaceuticals (ADIL) Bullish View Reiterated at Maxim Group Following Lead Asset Expansion
Oct 30, 2018 07:40AM Maxim Group Starts Adial Pharmaceuticals Inc (ADIL) at Buy